$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What are the common adverse reactions of dacomitinib? What should you pay attention to when taking it
2025-10-19 11:44:20
Check Details
What are the side effects of ramucirumab? What should you pay attention to during treatment
2025-10-19 11:44:20
Check Details
What are the adverse reactions of larotrectinib LOXO101? What are the precautions
2025-10-19 11:44:20
Check Details
What are the side effects of dacomitinib? Is the treatment effective?
2025-10-19 11:44:20
Check Details
What are the side effects of evantuzumab? Is evantumumab treatment effective?
2025-10-19 11:44:20
Check Details
Are there many side effects of Tepotinib Hydrochloride Tablets? What are the contraindications for medication
2025-10-19 11:44:20
Check Details
How long does it take for platinib to cause side effects? What should you pay attention to when treating platinib
2025-10-19 11:44:20
Check Details
What are the possible side effects of sotorasiib?
2025-10-19 11:44:20
Check Details
What are the side effects of alectinib in treating lung cancer? What are the precautions
2025-10-19 11:44:20
Check Details
What is the function of gefitinib? What are the side effects of long-term use
2025-10-19 11:44:20
Check Details
What are the side effects of topotecan? What is the usage and dosage?
2025-10-19 11:44:20
Check Details
What are the adverse reactions of tipotinib hydrochloride and how to deal with them?
2025-10-19 11:44:20
Check Details
1
2
...
4097
4098
4099
4100
4101
4102
4103
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
2
A Revolutionary Targeted Therapy for Hematological Malignancies
3
A New Option for Advanced Renal Cell Carcinoma Treatment
4
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
5
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
6
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
7
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
8
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
9
Comprehensive Analysis of the Third-Generation EGFR-TKI
10
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
11
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
12
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC